SPEAKERS CONFIRMED AS OF FEBRUARY 9th 2011 - Françoise Barré-Sinoussi , Nobel Prize in Medicine 2008, Professor , Head of Unit of regulation of retroviral infections, Institut Pasteur, Paris, INSERM, France - Zhu Chen , Health Minister, People’s Republic of China - José Angel Cordoba Villalobos , Health Minister, Mexico - Jean-Marie Lehn , Nobel Prize in Chemistry 1987, Professor, University Louis Pasteur, France - Antonio Tajani , Vice president, European Commission, in charge of Industry and Entrepreneurship - Roger Tsien , Nobel Prize in Chemistry 2008, HHMI Investigator, Professor of Pharmacology and of Chemistry & Biochemistry, University of California, San Diego, USA - Ada Yonath , Nobel Prize in Chemistry 2009, Professor, Weizmann Institute, Israel - Bernard Bigot , Chairman and CEO, French Alternative Energies and Atomic Energy Commission (CEA), France - Luis Cantarell , President & CEO Nestlé Health Science S.A., Switzerland - Esther Duflo , Professor, MIT, USA - Catherine Geslain-Lanéelle , Executive Director, European Food Safety Authority - Unni Karunakara , International President, MSF, Switzerland - Vishwa Mohan Katoch , Director, Indian Council of Medical Research - Michel Kazaktchkine , Executive Director, The Global Fund to fight AIDS, Tuberculosis and Malaria - Thomas Lönngren , Executive Director, European Medicines Agency (EMA) - Alain Mérieux , President, Institut Mérieux, France - Feike Sijbesma , CEO & Chairman Managing Board, Royal DSM NV, The Netherlands - Paul Stoffels, M.D., Worldwide Chairman, Janssen, Pharmaceutical Companies of Johnson & Johnson - Kim Stratton, Head, Group Country Management and External Affairs, Novartis - Christopher A. Viehbacher , CEO, Sanofi-aventis, France - Mark Walport , Director, Wellcome Trust, UK - Elias Zerhouni , Senior fellow, Bill & Melinda Gates Foundation, USA List of confirmed Speakers – BioVision 2011 – As of February 9 h 2011 - Jeffrey Almond , Head of Discovery Research and External R&D, sanofi-Pasteur - Jean-Claude Ameisen , President, Ethics Committee, INSERM, France (provisional agreement) - Olivier Appert , Chairman and Chief Executive Officer, IFP Energies Nouvelles, France - Philippe Archinard , President, Lyonbiopôle, Chairman and Chief Executive Officer, Transgene, France - Charles Auffray , Professor, CNRS, Genexpress team, France - Christian Béchon , Chairman and CEO, LFB, France - Alex van Belkum , Ph.D, Global Director, Microbiology Research, bioMérieux - Bernadette Bensaude-Vincent , Professor, University Paris 1 Panthéon-Sorbonne, President, Vivagora, France - Chris Bowler , Director of Environmental and Evolutionary Genomics, Institute of Biology, Ecole Normale supérieure, Paris, France - Pascale Briand , General Director for Food, French Minister of Food, Agriculture and Fisheries - Philip Campbell , Editor-in-Chief, Nature, UK - Andrew Cassels , Director of Strategy, Office of the Director General, WHO - Maria Cattaui , Member of the Board, Petroplus Holding AG, Switzerland - Olivier Charmeil , CEO, Sanofi-Pasteur, France - Bernard Chaud , VP for Biofuel Development, TEREOS - André Choulika, PhD, President, France Biotech, CEO, Cellectis, France - Jason Clay , Senior Vice President Market Transformation, WWF, USA - Pascale Cossart, Professor, Head of Cellular Biology and Infectious Diseases Department, Institut Pasteur, France - François Danel , Executive Director, Action contre la Faim, France - Christophe Dardel , President, DSM Biomedical, The Netherlands - Stanislas Dehaene , Director, INSERM-CEA Cognitive Neuroimaging Unit, Professor, Collège de France, France - Jacques Delort , Vice President Prospective and Strategic Initiatives, Sanofi-aventis, France - Don Deyo , Vice President, Product Development & Technology, Medtronic - Charlotte Ersbøll, Corporate Vice President, Novo Nordisk, Denmark - Alain Fischer , Professor, Head of INSERM research unit 768, University Paris Descartes, France List of confirmed Speakers – BioVision 2011 – As of February 9 h 2011 - Richard Frackowiak , Professor of Neurology Head of Clinical neurosciences department CHUV-UNIL, Lausanne, Switzerland - Alan Gara , Blue Brain Project, IBM, USA - James Geraghty , Senior Vice-President, Genzyme, USA - Michel Goldman , Executive Director, Innovative Medicines Initiative, Belgium - Marion Guillou , President, Institut National de la Recherche Agronomique (INRA), France - Claudie Haigneré , Chairwoman, Universcience, France - William N. Hait , M.D., Ph.D., Global Therapeutic Area Head, Oncology, Janssen Research & Development, Pharmaceutical Companies of Johnson & Johnson - Nicolaus Henke , Leader of the EMEA Healthcare Payors and Providers Practice, McKinsey & Company, UK - Matthew Hills , Head of Operations, Norwich Research Park, UK - Rob ten Hoedt , President, Europe, Medtronic, Switzerland - Liselotte Höjgaard , Professor, Department of Clinical Physiology and Nuclear Medicine, University of Copenhagen, Denmark - Leroy Hood , co-founder, Institute for Systems Biology, co-founder Amgen, Seattle, USA - Johan van Hoof, M.D., Global Therapeutic Area Head, Infectious Diseases & Vaccines, Janssen Research & Development, Pharmaceutical Companies of Johnson & Johnson - Donald Jones , VP, Health & Life Sciences, Qualcomm, USA - Manfred Kircher , Chairman, CLIB2021 (Cluster industrielle Biotechnologie 2021 e.V.), Germany - Béatrice Korc , Head, CCSTI, Rhône Department, France - Philippe Kourilsky , Professor, Collège de France - Denis Lacombe , Director, European Organisation for Research and Treatment of Cancer – EORTC Headquarters - Rob van Leen , Chief Innovation Officer, DSM Innovation Center, The Netherlands - Tom Lillie , International Development Executive Medical Director, Amgen - Edison T. Liu , President HUGO, Executive Director, Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR) - Pierre-Marie Lledo , Professor, Head of the unit "Perception et Mémoire", Institut Pasteur, France List of confirmed Speakers – BioVision 2011 – As of February 9 h 2011 - Gaëll Mainguy , Editor in Chief, S.A.P.I.EN.S, France - Michael Marmot , Director, International Institute for Society and Health, University College London, UK - Julia Marton-Lefèvre , Director General, IUCN, Switzerland - Peter Mueller , Executive Vice President Global Research and Development and Chief Scientific Officer, Vertex Pharmaceuticals, USA - Bernard Munos , Founder, InnoThink, USA - Denis Noble , Professor, President IUPS, Oxford University, UK - Helga Nowotny , President, ERC (European Research Council) - Anders Olauson , President, European Patient's Forum, Belgium - Rajesh Parekh, Director, Head of Healthcare Practice- Asia, McKinsey & Company, China - Eva Pebay-Peyroula, President, Agence Nationale pour la Recherche; Director, Institute of Structural Biology, Grenoble, France - Michel du Peloux , Sr VP, Head of Biofortis, Mérieux NutriSciences - Bart Peterson , Sr VP, Corporate Affairs and Communications, Eli Lilly & Company - Miroslav Radman , Professor PU-PH, INSERM, Laboratory of Evolutive and Medical Molecular Genetics, France - Andrea Rappagliosi , Chairman, Europabio, Belgium - Olivier Raynaud , Senior Director, Health Initiatives and Healthcare, World Economic Forum - Paul Ruebig , MEP, European Parliament, Member of the EPP Group, President, Science and Technology Options Assessment – STOA - Vincent Schachter , Vice President R&D, Total Gas and Power, France - Robert Sebbag , Vice president Access to Medicines, Sanofi-aventis, France - Ismail Seragedlin , Director, Bioblioteca Alexandrina, Egypt, Professor, Collège de France - Michel Serres , Philosopher and Member of the Académie Française, France - Jacques Suaudeau , Scientific Director, Pontifical Academy for Life, Italy - François Taddéi , Professor, INSERM, Laboratory of Evolutive and Medical Molecular Genetics, France - John A. Thomson , Vice President Research, Vertex Pharmaceuticals, USA - Didier Trono , Dean of the Life Sciences Faculty, EPFL, Switzerland List of confirmed Speakers – BioVision 2011 – As of February 9 h 2011 - Alan Trounson , President, California Institute for Regenerative Medicine, USA - Tran Thi Trung Chien , Former Health Minister, Vietnam, Chairwoman, Vietnam Association HIV/AIDS Prevention, President, Arm-Round Foundation - Yehong Zhang , President, Simcere Pharmaceuticals, China - Sonia Abdelhak , Professor, Institut Pasteur, Tunisia - Laurent Abel , MD, PhD, Director of Research at Inserm/University Paris Descartes, Head of the Laboratory of Human Genetics of Infectious Diseases, Necker medical school, France - Marc van Ameringen , Executive Director, Global Alliance for Improved Nutrition (GAIN), Switzerland - John Beard , Director, Department of Ageing and Life Course, WHO - Alim-Louis Benabid , Scientific Advisor, CEA, Minatec, Leti and Clinatec, France - Jean-Yves Blay , MD, PhD, Head of the Medical Oncology Department, Institute for Clinical Science, Centre Léon Bérard, France - Jean Bousquet , Professor of Pulmonary Medicine, University Hospital of Montpellier, France - Herb Brody , Supplements Editor, Nature - Anthony J. Brookes , Professor in Genomics & Bioinformatics, University of Leicester, UK - Rémy Burcelin , Professor, Research director, Institute of molecular medicine U858, INSERM, France - Anne Cambon-Thomsen , Professor, Genomics and Public Health, INSERM, France - Lucien Chabason, Senior Advisor, Institut du Développement Durable et des Relations Internationales – IDDRI; Former director, UNEP Mediterranean Action Plan, France - Kathrin Cohen Kadosh, Doctor,